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Renjun Zhu1, Adriana Blazeski1, Ellen Poon2, Kevin D Costa3, Leslie Tung1 and Kenneth R Boheler2,4*Abstract
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are the most promising source of cardiomyocytes
(CMs) for experimental and clinical applications, but their use is largely limited by a structurally and functionally
immature phenotype that most closely resembles embryonic or fetal heart cells. The application of physical stimuli
to influence hPSC-CMs through mechanical and bioelectrical transduction offers a powerful strategy for promoting
more developmentally mature CMs. Here we summarize the major events associated with in vivo heart maturation
and structural development. We then review the developmental state of in vitro derived hPSC-CMs, while focusing
on physical (electrical and mechanical) stimuli and contributory (metabolic and hypertrophic) factors that are
actively involved in structural and functional adaptations of hPSC-CMs. Finally, we highlight areas for possible future
investigation that should provide a better understanding of how physical stimuli may promote in vitro development
and lead to mechanistic insights. Advances in the use of physical stimuli to promote developmental maturation will
be required to overcome current limitations and significantly advance research of hPSC-CMs for cardiac disease
modeling, in vitro drug screening, cardiotoxicity analysis and therapeutic applications.Introduction
Human pluripotent stem cells (hPSCs) of embryonic
(embryonic stem cells (ESCs)) or experimental (induced
pluripotent stem cells (iPSCs)) origin [1-5] represent the
most viable cell source for in vitro generation of large
numbers of cardiomyocytes (CMs). The directed differen-
tiation of hPSCs to CMs has led to important research ad-
vances, including innovative platforms for the study of
human development and for disease modeling. It has also
reaffirmed the promise of cardiac regenerative medicine
with immunologically compatible cells. To date, research
has focused justifiably on cellular and molecular mecha-
nisms that control induction, differentiation, proliferation
and scalability of CM production [6,7]. These efforts have
led to CM differentiation protocols ranging from mono-
layer to cell aggregate systems with diverse chemical ad-
ditives (for example, bone morphogenic protein and* Correspondence: bohelerk@hku.hk
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2014activin agonists versus Wnt inhibitors) and a variety of
culture techniques (plate, flask, bioreactor) [6,7] that
can be employed for basic cell biology analyses [8,9],
generation of engineered tissue constructs [10-13], and
testing of regenerative potential after transplantation in
experimental models of heart failure [14].
Despite these advances, a major hurdle for the ex-
perimental and clinical use of these cells has been their
phenotypic ‘immaturity’ in vitro. In contrast to native
adult CMs, hPSC-derived CMs (hPSC-CMs) are char-
acterized as having small size and low capacitance, ab-
sence of T-tubules, lack of well-formed sarcomeres,
poor overall calcium storage and handling, absence of
multinucleation, relatively low numbers of mitochondria,
metabolic dependence on glycolysis, and innate automati-
city [15-18]. When transcriptionally compared to native
human cardiac muscle cells, hPSC-CMs most closely
resemble cells from embryonic or fetal heart [19].
Developmentally, physical cues and environmental
factors are paramount for the production of structurally
and physiologically mature CMs. In vivo, mechanical cues
from the cell surface (cell-cell and cell-extracellular matrix. The licensee has exclusive rights to distribute this article, in any medium, for 12
, the article is available under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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signals that can lead to phenotypic changes through a
process known as mechanotransduction (reviewed in
[20-24]). In fact, mechanical stretch and electrical ac-
tivity are extremely potent biological cues that, in the
heart, not only regulate contraction amplitude on a
beat-by-beat basis, but also drive mechanical and elec-
trical remodeling of the myocardium during cardiac
development, hypertrophy, and disease. Heart tissues
and individual myocardial cells experience not only
self-generated mechanical force, but also passive and
active stretching, all of which can activate mechano-
transduction pathways. These physical cues require
contact-dependent interactions of cells with ECM, with
other cells, as well as with physical features associated
with their environment (that is, topography). The fibrous
topography is associated with anisotropic alignment of
CMs within the heart [25] and gives rise to distinct
longitudinal and transverse structures, allowing for
directionally distinct pathways of force recognition and
transmittance [26,27]. Indeed, static transverse and longi-
tudinal loading can differentially activate stress-induced
mitogen-activated protein kinase (MAPK) [28] and alter
cardiac-specific protein secretion [29], while anisotropic
mechanosensing with focal adhesion kinase (FAK) phos-
phorylation has also been reported in neonatal rat ven-
tricular myocytes (NRVMs) [30]. Despite these scientific
advances, much less is known about the events that take
place in developmentally ‘immature hPSC-CMs’.
Here, we review structural components and physical
stimuli that may influence hPSC-CM developmental
maturation in vitro, and discuss data from animals and
humans to describe known mechanisms. We focus on
mechanical and electrical factors, and touch upon meta-
bolic and hypertrophic signals that have been implicated
in the adaptation of hPSC-CMs in two dimensions and,
where available, cells engineered in three dimensions.
We illustrate how in vitro differentiated hPSC-CMs can
respond to some of the same physical cues present in
embryonic, fetal and adult heart but point out that these
factors are preferably interpreted in a three-dimensional
context that can be recapitulated in vitro. We also high-
light areas that are currently not well represented in
published works, including the interactions with non-
myocytes and application of transcriptomics to electrical
and mechanical transduction events in hPSC-CMs. By
shedding light on these areas, future research advances
may overcome current limitations of hPSC-CMs for reli-
able disease modeling, drug discovery, cardiotoxicity
testing and studies of developmental maturation.
Heart development and physical cues
Heart development and cell growth involve dynamic inter-
actions between genetic and epigenetic or environmentalfactors [31] in a spatially complex manner [32]. In re-
sponse to transcriptional cascades and morphogen gradi-
ents, cells in the lateral plate mesoderm and secondary
heart fields commit to the CM lineage and presumably ac-
quire an epigenetic phenotype that impedes or prevents
de-differentiation. In the embryo and early fetal stages,
fully committed CMs increase organ mass mainly through
an increase in cell numbers (hyperplasia). During subse-
quent fetal and perinatal stages, mass increases through
hyperplasia and through increased cell size and volume
(hypertrophy). Post-natally, increases in cardiac mass
occur almost exclusively by hypertrophy. During the
perinatal period, hemodynamic loads increase dramatically
as the heart assumes its primary role as a circulatory
pump. Altered mechanical stimuli include a marked
pressure increase and large pulsatile volume changes. In
response to the increased work load and energy de-
mand, mitochondrial numbers increase, mitochondrial
oxidative metabolism is up-regulated as fatty acids become
available, while glycolytic metabolism becomes down-
regulated [33]. The major changes in cell phenotype and
function - including maturation of the sarcoplasmic
reticulum, reversal of the (initially negative) force-
frequency relationship [34], multinucleation, and the
localization of gap junctions to intercalated discs at cell
termini - all occur during the perinatal and early child-
hood periods. Heart rate, blood pressure, and diastolic
stiffness continue to change throughout adolescence
and into adulthood and old age. In the adult, the myo-
cardium consists of myofibrils composed of rod-shaped
CMs located next to fibroblasts and blood vessels, and
these cells are held in place by the ECM and physical in-
teractions with other CMs. The development and mat-
uration of CMs from the fetal to adult stages of life rely
on a balance between extrinsic and intrinsic mechanical
loads that regulate protein synthesis, sarcomere assem-
bly, cell size, contractile activity, and interactions with
other cells and the ECM [35], which together ultimately
determine the geometry and pump function of the heart.
Mechanical forces have a continuous and crucial regu-
latory role in cardiogenesis, cardiac growth, development
and maintenance. In the developing mammalian heart,
two types of contractile or intrinsic mechanical activity
are observed that are believed to involve actin-myosin
interactions. The first, which is beyond the scope of this
review, is cytoskeletal contraction, a process that drives
morphogenesis and cardiac looping [31]. The second is
associated with the rhythmic contraction of heart muscle
with each cardiac cycle, which subjects CMs to continuous
cyclic mechanical strain. Essentially, electrical excitation of
CMs is converted into mechanical movement through
excitation-contraction coupling, involving regulation of
cytosolic calcium and cycling of actomyosin cross-bridges.
Individual ventricular CMs experience changes in length
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actions are strongly influenced by external signals, like
venous return [36]. Through length-dependent (that is,
Frank-Starling mechanism) and frequency-dependent
contractile properties, contractility can be adjusted on a
beat-to-beat basis to accommodate changes in physiologic
activity and metabolic demand. When exposed to sus-
tained long-term changes in loading conditions, CMs
have the ability to remodel to maintain cardiac perform-
ance and restore homeostasis. CMs elongate in response
to increased diastolic strain by adding sarcomeres in
series, and they thicken in response to elevated systolic
stress by adding sarcomeres in parallel. Myocytes do
this while maintaining resting sarcomere length close to
its optimal value near the peak of the length-tension
curve.
Mechanical forces transmitted across the ECM or
between cells affect assembly and organization of the
ECM, gene transcription, growth, differentiation, apop-
tosis, signal transduction, electrical coupling and even tis-
sue morphogenesis [37-40]. Although little is known
developmentally, mechanical stresses during the cardiac
cycle in adult CMs are transmitted through the cytoskel-
eton and across cell-cell (intercalated discs) and cell-ECM
(focal adhesions) complexes to impact the dynamics of
physical shortening and tension development. Focal ad-
hesions at the ends of CMs and at costameres aligned
with Z-discs couple the ECM to transmembrane integrin
receptors. Integrins are cell surface, membrane-spanning
receptors that mediate cell-matrix interactions in all
higher organisms and are linked to the actin cytoskeleton
via adaptor proteins like vinculin, paxillin and α-actinin
[39]. These membrane proteins utilize a variety of
downstream kinases to regulate signals within the cells.
The major signal transduction molecule involves FAK,
which can regulate pathways involved in transcriptional
control, cell remodeling [41] and response to cardiac
hypertrophy [42].
Intercalated discs (ICDs) are highly organized inter-
cellular adhesion structures composed of fascia adherens
(adherens junctions), macula adherens (desmosomes) and
gap junctions. Fascia adherens and desmosomes are neces-
sary for mechanically coupling and reinforcing CMs [43].
Fascia adherens are the primary force-transmitting struc-
tures and are anchoring sites to the actin cytoskeleton.
They are composed of cadherins (N-cadherin), which are
responsible for Ca2+-dependent homophilic cell-cell adhe-
sion, catenin-related proteins (vinculin and α-actin) that
link the ICD to the cytoskeleton, and cytoplasmic catenins
(α-, β-, γ-catenin (plakoglobin)) that bind cadherins and
regulate their adhesive activity. α-Catenins are thought to
directly link the cytoplasmic domain of cadherin to the
actin cytoskeleton. Fascia adherens play critical roles in
cardiac development, disease and in arrhythmias [43].Desmosomes are also involved with force transmission
between CMs and play an important role to resist shear-
ing forces, which can arise from the laminar architecture
of myocardium [44,45], and can influence ion channel
trafficking to the CM membrane [46]. Desmosomes con-
tain desmosomal cadherins (desmocollin, desmoglein),
which bind to the armadillo family proteins (junctional
plakoglobin, plakopilin), which, in turn, anchor to a plakin
family member (for example, desmoplakin) that connects
to the intermediate filament cytoskeleton [47]. Over-
expression of N-cadherins in mouse models causes di-
lated cardiomyopathies, while desmosome mutations in
human lead to arrhythmogenic right ventricular dysplasia/
cardiomyopathy (ARVD/C) and impaired mechanical
coupling between individual cells with possible impair-
ment of electrical coupling [48,49]. Morphologically,
ICDs are normally arranged at the ends of adult CMs,
but in immature or diseased cells the adherens junc-
tions and gap junctions can be located on the lateral
sides of CMs.
Gap junctions are necessary for rapid electrical trans-
mission between cells [43]. They are composed of six
connexin molecules and form two half-channels across
an intercellular space. When connected, these junctions
provide a pathway for the passage of ions and small
molecules (<1,000 Da) between cells [50]. Connexin 43
(Cx43) and N-cadherin share a temporal relationship
both in expression and co-localization [39,51], and the
assembly of gap junction channels is preceded by the
formation of fascia adherens [52,53]. During postnatal
development, both Cx43 and N-cadherin are distributed
in human ventricular cells over the entire surface of the
cell. These molecules gradually redistribute to ICDs at
the longitudinal ends of the cell, reaching the adult pat-
tern at around 6 years of age [54], although a recent
study found that N-cadherin redistributes much more
quickly, by around 1 year of age [55]. Gene mutations in
connexins have rarely been found to be a cause for human
cardiac disease; however, remodeling of connexin isoform
expression and changes in gap junction organization are
typical traits of ischemic heart disease and failure [50].
Given the complexity of mechanical and structural in-
teractions just described in normal development as well
as genetic factors (Figure 1), it is challenging to isolate
specific mechanical signals that stimulate remodeling re-
sponses, particularly since stress and strain (deform-
ation) often co-vary in vivo and in vitro. External forces
from either passive or active wall stress in the heart can
increase resting cell length (if during diastole), resist cell
shortening (if during systole and less than the cellular
contractile force), and paradoxically lengthen the cell
(if during systole and greater than the contractile
force). Interestingly, significant CM shape change and
rearrangement of sarcomeres has been observed in vitro
AB
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Figure 2 Representative images of hPSC and hPSC-CM. (A)
Representative images of human pluripotent stem cells (hPSCs) (left),
a monolayer culture of hPSC-derived cardiomyocytes (hPSC-CMs;
unstained, middle), and dissociated and re-plated human embryonic
stem cell-derived cardiomyocytes immunostained with antibodies
against cardiac troponin T (TNNT2; right) [139]. (B) Cardiac troponin I
(TNNI3) immunostaining of a monolayer culture of human induced
pluripotent stem cell-derived cardiomyocytes at day 29 of differentiation
showing random patterns of striations. (C) Immunostaining of a
three-dimensional tissue strip with well-aligned troponin-stained
hPSC-CMs. Green, TNNT2 labeling (A, C), TNNI3 labeling (B); blue,
DAPI labeling.
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Figure 1 Schematic diagram illustrating developmental factors
that potentially impact the in vitro maturation process from
human pluripotent stem cell (hPSC)-derived cardiomyocytes to
an adult-like phenotype with highly organized sarcomeres and
intercellular junctions. This review focuses on physical
developmental cues from electrical stimulation and mechanical
loading, and also mentions factors including genetics, supporting
cells and substrate, metabolism, and both circulating and membrane
bound signaling molecules.
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muscle culture system [56] even in the presence of the
cross-bridge inhibitor 2,3-butanedione monoxime (BDM),
which diminishes systolic force. A lack of high shear stress
from intracardiac flow leads to abnormal heart develop-
ment in zebrafish embryos, indicating mechanical load
can also play an epigenetic regulating role [57]. Thus, a full
understanding of how mechanical and electrical forces
may influence hPSC-CM developmental maturation is a
challenging proposition, but one that should be amenable
to in vitro analyses designed to unravel cell autonomous
responses versus those that are manifested in response to
physical stimuli in two or three dimensions.
State of hPSC-CMs during differentiation
Experimental considerations
Relative to adult heart, hPSC-CMs display a develop-
mentally immature phenotype in vitro. The resulting
phenotype is not, however, constant as the differentiation
protocol, time of differentiation, presence of growth
factors and ancillary cells, as well as cultivation in two
dimensions versus three dimensions all influence thein vitro phenotype. Structurally, some of these differences
can be visualized by immunostaining with antibodies
against sarcomeric proteins like cardiac troponin T
(TNNT2) and I (TNNI3) (Figure 2). Under standard
two-dimensional conditions, the cardiac troponin ar-
rangements are random, while those in three-dimensional
tissue strips are much more aligned. Problematically, pub-
lished reports on physical cues that affect hPSC-CM struc-
ture and function have not taken variables associated with
in vitro differentiation into account. In fact, data from
hPSC-CMs have been obtained with divergent methods
ranging from highly efficient to inefficient differentiation
protocols that involve monolayers to cell aggregates
known as embryoid bodies (EBs) or cardiospheres
(Table 1). While most of the published data have
employed suspension EBs for generation of hPSC-
CMs, the time of cultivation and dissociation protocols
from suspension EBs have varied widely. Moreover,
when considering physical cues, it is crucial to con-
sider mechanisms that generate force as well as those
mechanisms that transmit and coordinate forces within
Table 1 Summary of methods and relative maturation states of in vitro derived cardiomyocytes
Study Method of differentiation Maturation state achieved and finding
Boheler et al. 2014 [139] Monolayer culture High purity hESC- and hiPSC-derived CMs
Cao et al. 2008 [59] Suspension EB Expression level of genes encoding structural and force-generating
proteins was comparable to fetal heart CMs
Caspi et al. 2009 [74] Suspension EB Presence of functional gap junctions
Chan et al. 2013 [102] Suspension EB Electrical field stimulation increased expression of cardiac-specific
genes
Stimulation promoted a ventricular-like phenotype
Stimulation improved calcium handling
Chung et al. 2007 [65] Suspension EB Mitochondrial oxidative metabolism is required for differentiation into a
functional cardiac phenotype
Foldes et al. 2011 [116] Suspension EB Showed active role for protein kinase signaling in hESC-CM growth
and hypertrophy
Gherghiceanu et al. 2011 [58] Suspension EB Ultrastructural features of early and immature phenotype:
Myofibrils with sarcomeric pattern
Large glycogen deposits,
Lipid droplets
Ca2+ release units detected on the sarcoplasmic reticulum
Underdeveloped intercalated disks
Spatial location of cells within EBs can affect their phenotype
Cx43 expression not detected
Kamakura et al. 2013 [62] Suspension EB Including long-term culture (up to 180 days)
Myofibrils became tightly packed and formed parallel arrays
Appearance of mature Z-, A-, H-, and I-bands
M-bands detected in 360-day-old EBs
Kehat et al. 2004 [75] Suspension EB hESC-CM tissue engraftment
Structural and electromechanical connections with NRVMs
Rate-responsive biological pacemaker
Kensah et al. 2013 [99] Cardiac bodies Formation of bioartificial cardiac tissue and use of defined
animal-free matrix
Kim et al. 2013 [83] Suspension EB Induction of adult-like metabolism is critical for establishing disease
onset in patient-specific iPSCs
Kim et al. 2010 [130] Suspension EB Co-culture with non-cardiomyocytes rescued the arrest of
electrophysiological maturation observed following hESC-CM
isolation from EBs in early culturesPurified CMs with a-MHC-Pac
R
Lundy et al. 2013 [60] Monolayer-based direct differentiation Late stage (about 100 days) cells exhibit
organized, longer sarcomeres with aligned Z-disks and organized
A- and I-bands
Dense and aligned myofibrils
Higher degree of multinucleation
MYH6 and MYH7 expression level comparable to adult human heart
Improved contraction, Ca2+ handling and AP characteristics
Matsa et al. 2014 [133] Suspension EB Allele-specific RNA interference can rescue diseased phenotype in
LQTS cardiomyocytes
Moore et al. 2008 [71] Suspension EB Cx43 mediates the expression of genes involved in cardiogenesis
Ou et al. 2011 [63] Hanging-drop EB Three-dimensional culture and cardiac fibroblast co-culture improved
sarcomere organization and Cx43 expression
Pal et al. 2013 [64] Suspension EB and monolayer-based
direct differentiation
Three-dimensional culture increased the expression level of TNNT2
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Table 1 Summary of methods and relative maturation states of in vitro derived cardiomyocytes (Continued)
Pekkanen-Mattila et al. 2010 [72] Suspension EB, Sparse, irregularly distributed Cx43 expression
END-2 co-culture
Poon et al. 2013 [19] Directed differentiation (suspension
EB)
Expression level of structural proteins are lower than in fetal
ventricular CMs
Purified ventricular phenotype
Sartiani et al. 2007 [61] Suspension EB, dissected CMs Electrophysiological characterization over a 3-month period
Maturation approaching an adult phenotype
Thavandiran et al. 2013 [101] Suspension EB iPSC-derived engineered cardiac tissue
Combination of a matrix-based microenvironment, uniaxial
mechanical stress and a mixture of cells improved engineered
cardiac tissue performance
Turnbull et al. 2014 [13] Suspension EB Expression of cardiac genes approached levels in adult LV
myocardium in engineered cardiac tissues
Xue et al. 2005 [76] Suspension EB Functional integration into myocardium
Cell-based pacemaker
Zhang et al. 2013 [12] Suspension EB Well-developed sarcomeric structures found in three-dimensional
cardiac patches
Upregulated E-C coupling and contractile genes
Zwi et al. 2009 [73] Suspension EB Sparse, irregularly distributed Cx43 expression
AP, action potential; CM, cardiomyocyte; Cx43, connexin 43; EB, embryoid body; E-C, excitation-contraction; hESC, human embryonic stem cell; hESC-CM, human
embryonic stem cell-derived cardiomyocyte; hiPSC, human induced pluripotent stem cell; iPSC, induced pluripotent stem cell; LQTS, long QT syndrome; LV, left
ventricular; NRVM, neonatal rat ventricular myocyte; TNNT2, cardiac troponin T.
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interactions through fascia adherens and desmosomes,
cell-ECM interactions through focal adhesions, cellular
electrical coupling through gap junctions, and signal
pathway and transcription factor activation in a two-
dimensional and three-dimensional context.Structural organization
Relative to adult heart cells, both human ESC-derived
CMs (hESC-CMs) and human iPSC-derived CMs (hiPSC-
CMs) are characterized by variable degrees of myofibrillar
organization, abundant glycogen, and underdeveloped
ICDs, all of which contribute to a developmentally imma-
ture phenotype [18,58]. While ultrastructural maturation
is analogous for both hESC-CMs and hiPSC-CMs, spatial
constraints can also affect their phenotype. In both hESC
and hiPSC EBs, cells on the periphery of the EB (small
round-shaped three-dimensional structure) are more
elongated, rod-shaped, have more oval nuclei, and often
have clear cross-striations, while cells in the center are
more densely packed, rounded, have more irregularly
shaped nuclei, and often have no visible striations [58].
One study, comparing hESC-CMs to fetal heart CMs,
found that expression of genes encoding structural and
force generating proteins was comparable [59]. Our own
transcriptomic study, however, indicated that structural
protein transcripts are frequently much higher in fetal
ventricular CMs than in hESC ventricular CMs [19],suggesting that additional stimuli are needed to produce
more transcriptionally active CMs.
Ultrastructural and functional maturation proceeds
during prolonged culture [60,61]. While early-stage
(approximately 30 days of differentiation) hESC-CMs
lack sarcomeric elements and exhibit disorganized and
sparse myofibrils, late stage (approximately 100 days of
differentiation) hESC-CMs and hiPSC-CMs can exhibit
organized, longer sarcomeres with clearly aligned Z-discs
and organized A- and I-bands, dense and aligned myo-
fibrils, and a much higher degree of multinucleation.
M-bands are detected at an even later stage (360 days
of differentiation) in hiPSC-CMs [62]. Late stage hPSC-
CMs exhibit up-regulation of cardiac structural genes en-
coding α- and β-myosin heavy chain (MYH6 and MYH7),
reaching levels comparable to those found in the adult hu-
man heart [60]. Maturation is also evident at a functional
level, with late-stage hPSC-CMs exhibiting improved con-
traction (higher magnitude and slower kinetics) compared
to early stage hPSC-CMs [60]. Three-dimensional culture
has also been shown to increase the organization of sar-
comeric myofilaments [63] and the level of TNNT2 [64]
in hESC-CMs. In three-dimensional human engineered
cardiac tissues, expression of cardiac genes approach
levels in adult left ventricular myocardium with increased
time in culture [13]. Transcripts encoding contractile and
Ca2+ handling proteins like MYH6, MYH7, TNNT2, L-
type Ca2+ channel, ryanodine receptor, SERCA2a and
CASQ2 are up-regulated in three-dimensional constructs
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hESC-CMs in three-dimensional cardiac patches fabri-
cated with a hydrogel consisting of Matrigel and fi-
brinogen exhibit well developed sarcomeric structures,
as evidenced by α-actinin and TNNT2 striations, longer
sarcomeres than in two-dimensional monolayers, and
up-regulated excitation-contraction coupling and con-
tractile function genes [12]. However, when compared
to spontaneously formed human EBs, MYH6 levels did
not differ in three-dimensional engineered heart tissues
(EHTs) [11].
Rodent and human membrane structures and organelles,
like mitochondria and sarcoplasmic reticulum, undergo
developmental changes during differentiation in vitro. Ca2+
release units, most likely involving ryanodine receptor iso-
forms, have been detected on the sarcoplasmic reticulum
[58], while cationic ion channels on the sarcolemmal
membrane exhibit expressional and functional differences
as a function of differentiation time [61]. At a functional
level, late-stage hPSC-CMs exhibit improved calcium
handling (faster calcium transient upstroke and decay)
and action potential characteristics (slower spontaneous
rate, faster maximum upstroke velocity, larger amplitude,
and hyperpolarized mean diastolic potential) than early-
stage hPSC-CMs [60]. In the undifferentiated state, mouse
ESC (mESC) mitochondria are spherical and exhibit
under-developed cristae, while those in mESC-CMs are
organized in extended, aligned networks and are rich in
cristae [65]. Mitochondrial development during the early
differentiation process progresses from random, peri-
nuclear localization to transcellular arrangement. These
changes occur in parallel with the development of the
contractile apparatus [65]. In humans, mitochondria
have similar morphology and distribution in hESC-CMs
and hiPSC-CMs derived from human follicle keratino-
cytes. While mitochondria in hESC-CMs and hiPSC-
CMs are closely associated with the sarcoplasmic
reticulum, contacts tethering the two organelles are
rarely found [58]. Mitochondria thus appear to undergo
structural developments with in vitro differentiation,
but the functional significance of these changes is poorly
understood. The influence of mechanical stimulation on
these structures and their function is unknown.
The application of three-dimensional cultures can
further accelerate functional and organelle maturation
of PSC-CMs relative to those found in two-dimensional
cultures. Lundy and colleagues [60] found that it took 100
days for hESC-CMs in two dimensions to exhibit more
advanced states of developmental maturation. In com-
parison, mESC-CMs grown as a suspension of cells in a
three-dimensional hydrogel, consisting of Matrigel and
fibrinogen and having an advanced structural design,
achieved significant maturation within as little as 3
weeks. Cells within these three-dimensional patcheswere aligned with abundant adherens and gap junctions,
were highly differentiated, and had fast anisotropic elec-
trical conduction and strong contractile forces [66]. The
same patch structure also resulted in advanced func-
tional maturation of hiPSC-CMs [67] and hESC-CMs
[12]. Thus, PSC-CMs, when incorporated into three-
dimensional tissue engineered constructs, are capable of
forming functional tissues with enhanced maturation
characteristics [67], and apparently more rapidly than
those cultivated in two-dimensional systems.
Electrical and mechanical junctions
Altered connexin expression in undifferentiated PSCs can
affect stem cell properties and differentiation to CMs;
however, the results have not been consistent. In the
undifferentiated state, Cx43 expression and functional
gap junctions are present [68,69], but down-regulation
of Cx43 using small interfering RNA can lead to a de-
crease in some stemness attributes [70]. Cx43-mediated
interactions, however, may not have any impact on
stemness of hESCs, since intercellular communication
of hESCs with Cx43-down-regulated human adipose-
derived stem cells had no effect on selected properties
of stemness [70]. Lentivirus-mediated over-expression
of Cx43 in hESCs impairs the development of functional
CMs in differentiated EBs [71]. Spontaneous beating
and expression of mesodermal markers are absent in
Cx43-enhanced EBs and, while Cx43-EBs express a var-
iety of gene transcripts associated with terminal cardiac
differentiation, the expression of TNNI3 and MLC2v is
delayed compared with control EBs. Further, a range of
genes affecting cellular growth and proliferation, move-
ment, differentiation, and maintenance are differentially
expressed in hESCs with over-expressed Cx43, pointing to
the role of Cx43 in both the maintenance of stem cell
properties and the regulation of cardiomyogenesis [70,71].
In hPSC-CMs, Cx43 may vary spatially and functionally
with time of differentiation and with culture conditions
[72,73]. Visualized by immunostaining, these junctions
often appear sparse and irregularly distributed at the cell
membrane, analogous to what is seen in mammalian de-
velopment. In one study, junctions were undetectable by
electron microscopy [58], but in another study, application
of a gap junction uncoupler, 1-heptanol, resulted in dose-
dependent conduction slowing, suggesting the presence of
functional gap junctions in hESC-CMs [74]. Consistent
with this assumption, Cx43 mRNA can be detected early
in hESC-CM differentiation. Its expression, however, may
depend on cultivation conditions, as transcript abundance
is enhanced by co-culture with murine embryonic fibro-
blasts [63]. Three-dimensional culture in a collagen matrix
combined with co-culture, which physically affects the
local environment, further enhances Cx43 expression at a
later stage of differentiation [63]. In advanced cardiac
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tions, but culture of hESC-CMs as a patch does not in-
crease the expression of the Cx43 gene when compared to
monolayer culture [12]. Additionally, beating hESC-CMs
are capable of pacing NRVM monolayers in co-culture
where Cx43 is expressed along the surface of contact
between the two cell types [75,76]. Finally, mESC-CMs
are connected to each other by ‘nascent ICDs’ com-
posed of fascia adherens and gap junctions [77,78], and
Lucifer yellow spreads to adjacent cells. Electrical propaga-
tion across these cells implies that PSC-CMs have some
form of functional electrical coupling.
Other than Cx43, an analysis of junctional complex
components and their relation to force generation in
hPSC-CMs is currently very limited. One study in
mESCs showed that FAK is a key regulator of cardio-
genesis that helps direct stem cell lineage commitment
[79]. Another study of hPSC-CM ultrastructure revealed
the presence of desmosomes and fascia adherens, but
the typical stepladder pattern characterizing ICDs was
not observed [37]. hiPSC- and hESC-CMs were, however,
connected by ‘primitive ICDs’ [58], which may contribute
to the immature electrical properties of these cells. Unlike
Cx43, over-expression of N-cadherin [80] in mESCs does
not interfere with the formation of functional CMs. In
fact, mESC-CMs that over-express N-cadherin show in-
creased levels of Cx43 [80], supporting the idea that
adherens junction formation drives connexin expression
[81]. N-cadherin has also been used as a surface marker
to identify human mesenchymal stem cells that reportedly
have increased cardiomyogenic differentiation ability [82].
iPSCs with mutations in desmosome proteins differenti-
ated into CMs exhibit calcium-handling deficits and can
be metabolically modulated to recapitulate adult ARVD/C
pathologies [83].
Mechanical and electrical stimulation of hPSC-CMs
Experimental considerations
Insights into mechanisms underlying the adaptive re-
sponses of cardiac cells to external forces have been
gained from in vitro studies of isolated cells, using pre-
cisely controlled timing, magnitude, and direction of
the mechanical stimuli [29,84-87] (Table 2). Substrate
stiffness [88,89] or applied cyclic stretching can signifi-
cantly impact size, elongation, alignment, protein syn-
thesis and contractile function of cultured CMs [90].
However, experiments such as these are not without sig-
nificant limitations. Many studies have been performed
on cultured neonatal rodent CMs using traditional two-
dimensional systems where CMs are grown on planar
substrates having supra-physiologic stiffness. This can
shield cell-cell junctions from mechanical stress during
active contraction and passive relaxation. Two-dimensional
structures typically fail to recapitulate important aspectsof the natural three-dimensional, anisotropic cardiac
mechano-environment that fundamentally impact the
cell biology [41,91]. When purified hESC-CMs have
been plated on extracellular matrix components layered
on top of a two-dimensional micropatterned design,
highly aligned cell aggregates with improved sarcomere
structures readily formed [92]; but these types of studies
lack an essential component of the myocardium - the
cardiac fibroblast [93]. By number, fibroblasts comprise
approximately 50% or more of cardiac cells and are a
major source of ECM production [94,95], the composition
of which is highly specialized in heart. Moreover, the lack
of aligned three-dimensional cell attachments and normal
electrical coupling in an appropriate topography and
environment is likely to adversely influence tension de-
velopment and other physiological traits.
To illustrate limitations associated with normal electrical
coupling, it is necessary to consider that all single cell
studies as well as most two-dimensional and three-
dimensional culture systems usually require enzymatic
disaggregation. When re-plated or allowed to form
tissue-like structures, the plating substrate, cell density
and timing of experimentation are critical variables. At
very low densities, cells are generally not in direct con-
tact, but retain ion channel activities, which can be
measured electrophysiologically. For whole cell patch
clamp studies, this is the ideal study design. When
intermediate cell plating densities are used, cell-cell
contacts form, but a highly coupled syncytium of hPSC-
CMs does not. When cells are dissociated and re-plated
at a relatively high density to promote syncytium forma-
tion, spontaneous electrical activity monitored by optical
mapping initially arises only in localized areas. The propa-
gation of these electrical activities is highly disorganized
across the monolayer (Figure 3) and is characterized by a
slow conduction velocity (Figure 3A-C). This delay may
indicate inappropriate gap junction formation. With time,
cells show improved electrical coupling, with a better
organized propagating wavefront and a much higher
conduction velocity (Figure 3D-E). In fact, conduction
velocities may continue to increase over a period of 1
month, indicative of a long-term reaction to autonomous
electrical activity [96]. Thus, enzymatically digested cells
require sufficient time to fully re-establish normal elec-
trical coupling, and the initial lack of directional electrical
coupling in high density two-dimensional, and by extrapo-
lation three-dimensional, cultures would be expected to
adversely affect contractile force production and down-
stream mechanosignaling.
Mechanical stimulation
Spontaneously contracting hPSC-CMs are usually plated
on ECM protein-coated tissue culture surfaces, which
can impact cardiac differentiation efficiency. The effect
Table 2 Effects of external factors on maturation
External factors Effects on developmental maturation Reference
Substrate stiffness/ Affects differentiation efficiencies. Intermediate-stiffness hydrogels lead
to the highest efficiencies
Hazeltine et al. 2014 [97]
Two/three-dimensional
culture
Increases organization of sarcomeric myofilaments Ou et al. 2011 [63]
Zhang et al. 2013 [12]
Increases cardiac gene expression Pal et al. 2013 [64]
Turnbull et al. 2014 [13]
Increases contractile and Ca2+ handling protein expression Tulloch et al. 2011 [10]
Zhang et al. 2013 [12]
Promotes alignment and anisotropy Liau et al. 2011 [66]
Promotes functional maturation in general Christoforou et al. 2013 [67]
Two-dimensional alignment and groove widths between 30 and 80 μm
promote alignment and improve sarcomere structures
Salick et al. 2014 [92]
Mechanical stimulation Increases expression of cardiac α-actin and MYH6, and enhances expression
of cardiac transcription factors
Gwak et al. 2008 [98]
Improves tissue morphology and enhances active force levels Kensah et al. 2013 [99]
Increases cell alignment Tulloch et al. 2011 [10]
Schaaf et al. 2011 [11]
Thavandiran et al. 2013 [101]
Zhang et al. 2013 [12]
Increases proliferation rates Tulloch et al. 2011 [10]
Increases AP duration and upstroke velocity, but leads to a less negative MDP Schaaf et al. 2011 [11]
Increases cell size, cytoskeletal assembly and sarcomeric organization Foldes et al. 2011 [116]
Cyclic stretch improves TNNT2 and Cx43 expression, increases contraction rates
and shortens calcium transients
Mihic et al. 2014 [100]
Electrical stimulation Leads to better structured and organized myofilaments Lieu et al. 2013 [15]
Produces cell elongation, affects expression of a group of cardiac-related genes Chan et al. 2013 [102]
Chen et al. 2009 [104]
Improves cardiomyocyte alignment, cross-striation patterns and force development Hirt et al. 2014 [103]
Energy substrate Elicits ARVD/C phenotype of increased apoptosis, elevated lipogenesis, and
impaired calcium handling in PKP2 mutants
Kim et al. 2013 [83]
Galactose and fatty acids increase oxidative phosphorylation levels, reserve capacity, and
maximum respiratory capacity in mitochondria
Rana et al. 2012 [120]
Glucose depletion along with lactose supplementation increase cardiomyocyte
purity
Tohyama et al. 2013 [121]
Induction of mitochondrial biogenesis increases cardiomyocyte differentiation Prowse et al. 2012 [126]
Other Stimulating p38-MAPK increases cell size, improves sarcomere and cytoskeletal
assembly
Foldes et al. 2011 [116]
Heineke and Molkentin 2006 [117]
Thyroid hormone increases cardiomyocyte size, sarcomere length, contractile force
and anisotropy
Yang et al. 2014 [18]
Adrenergic agonists produce hypertrophy Foldes et al. 2011 [116]
IGF1 together with electrical or electromechanical stimulation improve NRVM
engineered tissue function, SERCA2a and TNNT2 expression
Park et al. 2014 [119]
Morgan and Black 2014 [118]
AP, action potential; ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; Cx43, connexin 43; IGF-1, insulin-like growth factor 1; MAPK, mitogen-
activated protein kinase; MDP, maximal diastolic potential; NRVM, neonatal rat ventricular myocyte; TNNT2, cardiac troponin T.
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by culturing hESCs on polyacrylamide hydrogels of
different stiffness spanning the physiological range.Substrates with intermediate-stiffness hydrogels led to
the highest differentiation efficiencies [97]. This sub-
strate effect depended on the developmental stage of
Figure 3 Optical characterization of hPSC-CM electrophysiology. Optical mapping of enzymatically digested and re-plated human induced
pluripotent stem cell-derived cardiomyocyte monolayers recorded 9 days (A-C) and 13 days (D-F) after re-plating. (A) Transmembrane voltage
map of 9-day re-plated monolayer. (B) Activation time map and local conduction velocity vectors of (A). (C) Action potential recorded from
location indicated by white box in (A). Electrical coupling among the cells of this 9-day old monolayer is poor, as indicated by the disorganized
activation time map, rough wavefront of the propagating AP and slow conduction velocity (5.4 cm/second). (D) Transmembrane voltage map of
a 13-day re-plated monolayer. (E) Activation time map and local conduction velocity vectors of (D). (F) Action potential recorded from location
indicated by white box in (D). Electrical coupling was much improved with increased time in culture, as indicated by the near planar propagating
action potential as well as faster conduction velocity (10.5 cm/second). Dashed lines in (C) and (F) indicate the time points of the corresponding
transmembrane voltage maps in (A) and (D).
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stages of cardiac specification (that is, mesodermal pro-
genitors) had an apparent loss of substrate sensitivity
when compared to hESCs [97].
In contrast to conventional two-dimensional culture of
hPSC-CMs on stiff tissue culture surfaces or in suspen-
sion as spontaneously formed EBs, three-dimensional
culture systems provide a biomimetic environment with
controlled biological complexity that can yield valuable
insights into the roles of specific physical and mechan-
ical stimuli in the development of CMs. By applying ex-
ternal mechanical stress to the entire three-dimensional
construct through custom-made or commercially available
loading systems or by varying the matrix composition
(and thereby its stiffness), it is possible to control both the
static and dynamic load experienced by hPSC-CMs.
mESC-CMs under continuous stretch, for example, show
increased expression of cardiac α-actin and MYH6 and
enhanced expression of transcription factors like Gata4
and Nkx2.5. These stretched cells reportedly form better
cell-cell connections that facilitate synchronous contrac-
tion both in culture and after implantation onto infarcted
rat hearts [98]. Differentiated CMs can also change their
structure to align with an applied mechanical stress. In-
creasing stepwise stretch of mouse iPSC-CM tissue con-
structs improved tissue morphology (enhanced cellular
alignment and sarcomere organization), produced longer
sarcomeres, and enhanced active force levels [99]. In
hESC- and hiPSC-CM constructs, both static and cyclicuniaxial stress increased cell and matrix fiber alignment,
although not to the level observed in adult rat heart [10].
A similar response was observed in an hESC-CM EHT
model, where the constructs were subject to mechanical
loads produced by their spontaneous contraction. The
CMs showed predominantly longitudinal orientation along
force lines [11]. In a separate study, cyclical stretch of
hESC-CMs seeded onto scaffolds had a greater proportion
of TNNT2-positive cells relative to non-stretched controls
[100]. The stretched cells were elongated, and demon-
strated increased Cx43 expression and faster contraction
rates with shorter calcium transient times. In addition to
engineered tissue strips, hPSC-CMs in engineered tissue
patches also displayed highly aligned CMs in response to
stress. Elongated and oriented cells have been observed
within the cardiac patches at locations where high uniaxial
stress is expected [101]. Notably, the uniformity of CM
alignment can be improved by locally controlling the dir-
ection of passive tension within the cardiac patch [12].
Mechanical load influences proliferation and sarco-
meric organization of hPSC-CMs. Proliferation rates of
CMs increased by 21% in cardiac constructs conditioned
by cyclic uniaxial stretch relative to unconditioned con-
structs, and a further increase in proliferation was ob-
served by addition of non-myocyte (endothelial or
stromal) supporting cells [10]. Sarcomere organization
in stress-conditioned cardiac constructs exhibits cross-
striated patterns, similar to native tissue. Contractility of
these tissue constructs also benefits from the application
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tropic responses to beta-adrenergic stimulation [10,12]. It
is likely that these results can be attributed, at least in part,
to the influence of the three-dimensional environment on
the cells. In summary, more organized sarcomere struc-
tures, increased transcriptional expression of contractile
proteins and improved contractility suggest a more mature
CM phenotype in mechanically conditioned EHTs.
The presence of passive or active mechanical stimuli
improves the electrophysiological function of hPSC-CMs.
Microelectrode recordings of cells isolated from EHTs
showed an increase in action potential duration and up-
stroke velocity compared with CMs isolated from human
EBs of similar age, but the maximal diastolic potential
(MDP) was less negative [11]. This depolarized MDP may
explain the improved excitation threshold and maximum
capture rate observed in another study, where MDP was
not reported [101]. The conduction velocity can be
significantly higher in tissue constructs as opposed to
two-dimensional monolayers [12], and in one report
even approaches the values of native human heart [101].
The improved electrical conduction is probably due to
improved cell alignment with good connectivity more
analogous to that found in adult tissue [11]. On the
other hand, electrical function-related genes, such as
GJA1 (Cx43), SCN5A (Nav1.5), KCNH2 (Kir2.1), and
CACNA1C (Cav1.2), do not seem to have enhanced
expression in three-dimensional cultures [12].
Electrical stimulation
Cardiomyocytes are constantly subjected to electrical
signals in vivo that promote synchronous contractions,
and electrical activity provides important instructive cues
during growth and development of the heart. Although
limited work has been published, current data suggest that
electrical stimulation promotes aspects of hPSC-CM mat-
uration. Chronic electrical pacing of hESC-CMs at 1 Hz
for 2 weeks resulted in more mature cells characterized
by better structured and organized myofilaments [15].
Electrophysiological maturation was also evident as
cells showed suppressed spontaneous activity, hyperpo-
larized resting potential, increased intracellular calcium
transients, and increased expression of resting ion
channel (Kir2.1), calcium handling (CSQ2, junctin, tria-
din, SERCA), structural (Cav3, Amp2) and contractile
(myosin heavy chain (MHC), myosin light chain (MLC))
proteins. In another study on hESC-CMs, electrical stimu-
lation for 4 days produced cell elongation, increased action
potential duration, increased calcium transients, increased
expression of ion channel (HCN1, SCN5A, Kv4.3), cal-
cium handling (SERCA), and contractile (MLC2v) genes,
and decreased the expression of other ion channel genes
(HCN3, KCNQ1, KCNH2) [102]. No change was found in
maximum diastolic potential. In hiPSC-CMs engineeredto form spontaneously beating EHTs, electrical field
stimulation at 1.5 to 2 Hz for at least 10 days led to
CMs with improved alignment, improved cross striations,
an elongated shape, a higher cytoplasm-to-nucleus ratio,
and improved force development [103]. In other species,
biphasic pulse trains produced dose-dependent increases
in β-MHC and troponin-T expression in differentiating
mESCs [104]. In isolated NRVMs, electrical pacing
produced periodic contraction and induced cell align-
ment and coupling, markedly improved ultrastructural
organization, and increased amplitude of contraction
of NRVMs seeded on collagen sponges [105]. Pacing
has also been shown to modulate action potential dur-
ation, Kv4.3 expression, calcium handling (NCX) expres-
sion, and conduction velocity in NRVM monolayers [106],
and it increased excitability and expression of Cx43 in
NRVMs cultured with endothelial cells in a polyethylene
glycol diacrylate gel [107]. In spontaneously beating EHTs
composed of NRVMs, electrical stimulation led to a more
physiologic rightward shift in the force response curve to
external calcium, higher CM density in the center of the
EHT, increased Cx43 expression, and improved sarcomere
ultrastructure with regular M-bands [103]. While there is
general agreement in the literature with respect to the
maturation effects of electrical stimulation, studies with
NRVMs suggest that the best that can be achieved is an
age-matched native phenotype rather than the adult
phenotype [108].
Mechanistically, electrical stimulation initiates and co-
ordinates cellular contraction, which regulates cell and
tissue structure and function during development [40].
The beneficial effects of electrical pacing are likely to be
mediated through the activation of intrinsic forces asso-
ciated with cellular contraction, in particular, those aris-
ing from dynamic loading conditions at focal adhesions,
at fascia adherens and desmosomes, and along elements
of the cytoskeleton. Increases in protein synthesis and
accelerated cell growth occur in neonatal rat and adult
feline CMs with electrical stimulation, and are prevented
when contraction is inhibited either by the addition of
calcium channel blockers or the contraction inhibitor
BDM [84,109]. Electrical pacing may even have a greater
stimulatory effect than externally applied stretch under
some conditions [84], suggesting that mechanisms other
than mechanical forces alone may spur maturation. The
opening of calcium channels with electrical stimulation
causes cyclic intracellular calcium transients, which can
regulate a host of intracellular signaling pathways [110].
A single, long duration (90 seconds) DC electric field
pulse can increase intracellular reactive oxygen species
(ROS) and augment cardiac differentiation of non-
contracting hESCs [111]. In mouse, electric fields also
can augment cardiac differentiation, activate ROS and
produce broad transcriptome changes [104], including
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kappa B [112].
Other investigations on animal CMs indicate that
electrical stimulation may be a viable approach for
effecting metabolism, hormonal signaling (also see next
section), and CM recruitment. NRVMs electrically
stimulated in the presence of a contraction inhibitor
experience up-regulation of several genes involved in
metabolism: Bckdha, encoding a keotacid dehydrogen-
ase, Cpt1b, encoding carnitine palmitoyltransferase 1b,
Gpam, encoding glycerol-3-phosphate acyltransferase,
and Hadh, encoding hydroxyacyl-CoA dehydrogenase
[113]. Further, electrically stimulated adult rat CMs
exhibit an increase in the rate of GLUT4 exocytosis
but no change in the rate of GLUT4 endocytosis when
compared to unstimulated controls [114]. Electrical
stimulation of NRVMs at 5 Hz results in increased expres-
sion of COX and Cyt C mRNA, which are associated with
mitochondrial proliferation. These are preceded by up-
regulation of the transcriptional activation factor genes
c-fos, c-jun, JunB, and NRF1 [115]. Finally, the improved
function of chronically paced EHTs may be due to both
increased recruitment of CMs that participate in coordi-
nated contraction as well as improved function of single
CMs [103].
Hypertrophic signals and metabolic adaptations
Post-natal physiological growth is stimulated by increased
workloads and biomechanical stress (that is, physical
cues), which stimulate hypertrophic responses and
metabolic responses in CMs that may also influence the
developmental maturation of hPSC-CMs. These in vivo
stresses can be sensed by stretch-sensitive ion channels
or integrins linked with cytoskeletal proteins that acti-
vate a plethora of signaling cascades, often involving
calcium. Some of these signaling cascades are likely in-
trinsic to hESC-CMs, because equiaxial cyclic stretch
promotes an increase in cell size, cytoskeletal assembly
and improved sarcomeric organization in two-dimensional
cultures [116]. We have also observed that hPSC-CMs
cultivated in serum produce larger cells (particularly with
some iPSC lines) than those cultivated in fully defined,
serum-free conditions. Stimulation of the p38-MAPK sig-
naling cascade, which in rodent responds to serum, leads
to an increase in cell size, improved sarcomere and cyto-
skeletal assembly, and physical cell traits like elongation
that are consistent with more mature cells [116,117].
Thyroid hormone, a known hypertrophic stimulatory
hormone, increases CM size, sarcomere length, con-
tractile forces and anisotropy of iPSC-CMs, while sim-
ultaneously reducing cell cycle activity [18]. Similarly,
adrenergic agonists that affect cardiac function and
growth like phenylephrine (α-adrenergic agonist) pro-
duce hypertrophy, while isoproterenol (β-adrenergicagonist) only affects chronotropic activity in two-
dimensional cultures [116]. Mechanical stimulation
coupled with delayed electrical activation, unlike elec-
trical or mechanical stimulation alone, improved SER-
CA2a and TNNT2 expression in NRVM engineered
tissues. These improvements were due in part to the
increased expression and phosphorylation of AKT/
PKB, an important downstream target for insulin-like
growth factor 1 (IGF-1)/phosphoinositol-3-kinase medi-
ated hypertrophic growth [118]. Consistent with a growth
role for IGF-1 in these cells, Park and colleagues showed
that the combined effects of IGF-1 and electrical stimula-
tion can improve the overall contraction strength, sarco-
mere development and Cx43 expression of NRVM cardiac
tissue constructs [119].
The heart undergoes significant metabolic changes
during the perinatal period, only a few of which have
been demonstrated in PSC-CMs. Undifferentiated PSCs
from mouse and human depend on glycolysis, and mESCs
have lower basal respiratory rates, lower maximal respira-
tory capacity, and increased glycolysis than mESC-CMs.
The latter exhibits higher energetic requirements that ne-
cessitate some degree of oxidative metabolism [65]. When
compared to fetal heart CMs, hESC-CMs differ in energy
metabolic processes involving the Krebs cycle, cellular res-
piration, mitochondrial biogenesis, and lipid metabolism
[59]. hiPSC-CMs rely principally on glycolysis when cul-
tured in media containing glucose, even if present at low
levels and when fatty acids are available [120]. hiPSC-
CMs, however, can shift to oxidative phosphorylation for
ATP generation when cultured in galactose-containing
media. When cultured under these conditions or supple-
mented with fatty acids, hiPSC-CMs exhibit higher reserve
and respiratory capacities, and more closely resemble the
bioenergetics of adult CMs [120]. Whether the activated
oxidative phosphorylation in galactose media represents a
normal metabolic induction or a stress response remains
unclear. By taking advantage of the fact that lactate is used
in Krebs cycle metabolism by CMs but not by non-CMs,
glucose-depleted and lactose-supplemented media enrich
for hESC-CMs and hiPSC-CMs [121]. This effect can be
attributed both to the fact that ESCs have a lower expres-
sion of genes encoding enzymes involved in the Krebs
cycle and are unable to obtain large amounts of ATP
by oxidative phosphorylation or by glycolysis under
glucose-deprived conditions. These cells are unable to
convert lactate to glucose-6-phosphate for use in the
Krebs cycle because it requires the expenditure of ATP
[121]. It is, however, unclear what types of CMs are
isolated following lactate purification. Finally, use of a
five factor cocktail to promote adipogenesis and fatty
acid metabolism in ARVD/C mutant containing iPSC-
CMs promoted manifestation of the disease phenotype
in vitro. This phenotype could not be reproduced in
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tabolism can be used to promote a more adult-like
phenotype critical to study disease pathogenesis [83].
Although the effects of mitochondrial function and
metabolism on the maintenance of pluripotency, as well
as on PSC reprogramming and differentiation efficiencies,
have been aptly covered by several reviews [122-124], a
few points are worth mentioning. Differentiation of hESCs
is characterized by increases in mitochondrial mass and
DNA content, as well as an increase in ATP and ROS
[125]. Further, mesodermal commitment can be affected
by chemically induced changes in mitochondrial biogen-
esis [126]. Work in mESCs suggests that disruption of the
mitochondrial respiratory chain during early differenti-
ation of ESC-CMs not only compromises mitochondrial
content, localization, and arrangement, but also dis-
rupts sarcomere formation, resulting in a decreased
yield of functional CMs [65]. In undifferentiated hESCs,
mitochondria exhibit perinuclear organization and a
rounded phenotype [126], while differentiation results
in the development of branched mitochondria into an
extensive network [127]. Thus, mitochondrial function
may be critical to structural changes that occur in
hESC-CMs in response to mechanical loads. Given the
complexity of metabolic and mitochondrial adaptations
that occur during development and in vitro, readers are
directed to in-depth reviews of mitochondrial biogen-
esis for further information [128,129].
Future areas of investigation
To better understand the mechanisms of mechanical and
electrical cues on developmental properties of PSC-CMs,
a number of variables need to be considered. First, CMs
in vivo do not function alone, and are normally in contact
with fibroblasts, smooth muscle cells and other vascular
cells. Kim and colleagues [130], for example, showed that
purified hESC-CMs isolated from early EB cultures failed
to develop adequate intracellular Ca2+ handling protein
and ion channel functions associated with electrophysio-
logical maturation. The addition of non-CMs to the puri-
fied cells, however, could rescue this developmental loss,
presumably either through cell-cell contact or the release
of paracrine factors. Moreover, three-dimensional cardiac
tissues form best when co-cultured with multipotent
stromal cells or fibroblasts [101], but their contributions
to structural and mechanical stimulation are unknown.
Second, in depth transcriptomic analyses should be
considered. While microarrays have been performed on
two-dimensional cultures of PSC-CMs and compared
with those performed on fetal heart samples, no analysis
has systematically compared PSC-CMs subjected to
physical stimulation in both two and three dimensions.
In the absence of targeted mechanical or electrical in-
terventions, these analyses are likely to be difficult tointerpret since both electrical and mechanical stimula-
tion can affect signaling cascades, nuclear signaling,
transcription, metabolism and remodeling. Identifica-
tion of specific electromechanical sensitive signaling
pathways will require experimental interventions to un-
couple stress, strain, electrically regulated forces during
adaptive phases of remodeling, and complex data set
analyses to unravel mechanisms. Similar to what has
been done for pluripotency with hPSCs, it is likely that
transcriptomic profiles may be able to define develop-
mental maturation stages of in vitro derived CMs [131].
Third, iPSCs derived from patients with mutations that
affect mechanical and/or electrical properties of PSC-
CMs are likely to be highly informative. In vitro studies
using iPSCs derived from probands with ARVD/C, a
disease of the desmosome, have already shown that the
induction of adult-like metabolism is critical for the es-
tablishment of this disease [83]. Moreover, cells with
mutations in HERG/KCNH2 channels that cause long
QT syndrome 2 have prolonged action potential dura-
tions and other electrical abnormalities that may affect
maturation processes [132,133]. It is also possible that
altered epigenetic states in iPSCs may respond differ-
ently to mechanical signals and electrical stimulation.
Theoretically, iPSCs might contain residual epigenetic
memory of the founder line (for example, fibroblasts or
blood), which could affect cytoskeleton proteins and
signal transduction through the cytoskeleton differently
than in CMs derived from PSCs. Detailed studies of this
process, however, suggest that epigenetic memory may
be short-lived in high quality iPSC lines, and that it may
depend on the tissue of origin [134,135]. Fourth, stretch-
sensitive ion channels represent a potentially informative
line of investigation that has implications not only for
physical cues like stretch, but also for hypertrophic
signaling. Moreover, ionic current flow and voltage
gradients could be the basis for long-range signaling
that could coordinate tissue growth and function [136].
Downstream signaling events that may be activated in
response to mechanical (for example, stretch-sensitive
channels) and electrical stimuli (ion and voltage-dependent
channels) must also be considered. Intrinsic to this analysis,
the role of the cytoskeleton and the ECM will need to be
emphasized. Ultimately, attempts must be made to under-
stand how any activated signaling cascade interfaces with
intrinsic or cell autonomous maturation pathways. Finally,
the identification of reference markers to assess hetero-
geneity and cell maturation will be critical to future stud-
ies designed to understand the responses of hPSC-CMs to
stimuli. Although often ignored, human PSC-CMs are
highly heterogeneous and can consist of multiple cell
types. The ventricular, atrial and nodal cell types typically
generated with in vitro differentiation also display different
‘maturation’ states. Ultimately, improved surface markers
Note: This article is part of a thematic series on Cardiovascular
regeneration edited by Ronald Li. Other articles in the series can
be found online at http://stemcellres.com/series/cardiovascular.
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cytometry to assess heterogeneity and cell quality, as well
as the isolation of sub-populations of hPSC-CMs with
known traits. Although markers like VCAM1 and SIRPA
have been identified as useful for isolating hPSC-CMs,
these markers do not distinguish among subtypes of mat-
uration states [137,138]. Accordingly, optimized staining
and isolation protocols will be required to advance this
field and further studies involving physical cues.
Conclusion
Significant research efforts have been undertaken to im-
prove the generation and quality of hESC and hiPSC cell
lines, and delineate mechanisms that promote CM com-
mitment and differentiation. This has led to significant
advances in our ability to routinely generate tens to
hundreds of millions of hPSC-CMs for investigative or
therapeutic applications. A major limitation to the use
of these cells is their relative developmental immaturity.
Human PSC-CMs are most similar to CMs obtained
from embryonic or fetal hearts. Arrhythmic properties
and weak contractile forces, in particular, pose con-
founding problems for disease replacement therapies;
however, these same properties may prove valuable as
models for drug screening, in terms of increased assay
sensitivity. The in vitro differentiation system also has
inherent deficiencies that may limit our ability to generate
functional heart muscle. One of the major limitations is
the lack of the normal organogenesis, of morphogens and
growth factor gradients, and of blood circulation, all of
which contribute to normal heart development and func-
tion. It therefore remains an open question as to whether
terminal maturation of hPSC-CMs can be fully achieved
in vitro. Post-transplantation of hPSC-CMs has, however,
resulted in CMs with well-developed sarcomeric struc-
tures and morphologies similar to those found in adult
heart. These latter results indicate that hPSC-CMs are
fully committed and capable of forming functional heart
muscle without normal organogenesis, but it remains un-
clear how similar they are to native myocardium.
The application of physical cues (electrical and mechan-
ical) that occur during in vivo cardiac development may
prove critical for maturation of hPSC-CMs in vitro. The
goal would be to replicate cardiac perinatal development
and to understand the mechanisms responsible for these
adaptive changes. To achieve this goal, we submit that
hPSC-CMs, and ultimately ventricular CMs with defined/
known developmental stages, will need to be examined
in complex three-dimensional tissue constructs that can
be subjected to mechanical, electrical, hypertrophic and
metabolic stimuli. Unlike traditional two-dimensional
systems, these engineered constructs should allow for
dynamic feedback between electro-mechanical signaling
and ECM remodeling, as well as adaptive changes in celland tissue architecture, analogous to what naturally occurs
in the heart. Coupling advances in three-dimensional
tissue design with physical cues should lead to the de-
velopment of more natural cardiac tissues amenable to
robust mechanistic analysis that have clinical relevance
for modeling and eventually treating cardiac syndromes.Abbreviations
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